Nonnucleoside Reverse Transcriptase Inhibitors
- Name
- Nonnucleoside Reverse Transcriptase Inhibitors
- Accession Number
- DBCAT003641
- Description
Not Available
- Drugs
Drug Drug Description Nevirapine A non-nucleoside reverse transcriptase inhibitor used as part of a management regimen for HIV-1 virus infection. Efavirenz A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection or prevent the spread of HIV. Delavirdine A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. Etravirine A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents. Rilpivirine A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1). Doravirine A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. - Drugs & Drug Targets